Galactosidases

DBCAT000216Pharmacologic class

A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-. A DrugBank category of 4 drugs. 4 of them are approved.

Also known as: Galactosidase
Drugs: Agalsidase alfa
Agalsidase beta
Pegunigalsidase alfa
Tilactase

What you can answer from here — as of August 24, 2016

4DrugsEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

65Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Galactosidases share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account